Jose O. Solbiati, Ph.D.

Dr. Solbiati is currently conducting research at the University of Florida. He also served at the University of Illinois for over 10 years after being employed both in Argentina and Spain upon completion of his PhD in Argentina. Dr. Solbiati has been collaborating with Dr. Dennis Buetow and Dr. Indu Rupassara on the research related to genetic engineering to stabilize the RSV gene.
More Details

Jagdeep S. Sandhu, Ph.D.

Dr. Sandhu obtained his PhD from the University of Cambridge, UK, in 1996. He conducted postgraduate research on transfer of the RSV fusion-protein into plants, at the University of Illinois at Urbana-Champaign (1996-2000, in Buetow-lab), and then as a biotechnologist at the Punjab Agricultural University, India, where he is employed at present.
More Details

Erik Nelson, Ph.D.

Erik Nelson received his Bachelors of Science from the University of Calgary, majoring in zoology and minoring in chemistry. He continued at the University of Calgary, receiving a PhD in comparative endocrinology. He then moved to Duke University School of Medicine to pursue postdoctoral studies specializing in pharmacology and cancer biology. In 2014, he was recruited to the University of Illinois at Urbana-Champaign, where he is an Assistant Professor of Molecular and Integrative Physiology. His research program is focused on how hormones and cholesterol metabolism impact breast and ovarian cancer progression. In recognition of his research, Dr. Nelson has been awarded the Government of Alberta Queen Elizabeth II Graduate Scholarship, a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award, and a National Cancer Institute Pathway to Independence Award.

Hugh S. Mason, Ph.D.

Dr. Mason was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continue to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.

More Details

M. Kathleen Buetow, MD, DrPH

Dr. Buetow received an MD from the University of Maryland in 1954 and subsequently did a Pediatric Residency at Baltimore City Hospitals and Cincinnati Children’s Hospital. She then returned to Baltimore to pursue a Doctor of Public Health degree at Johns Hopkins School of Hygiene and Public Health with her thesis work on the topic of Neonatal Mortality. She became a diplomat of the American Academy of Pediatrics (AAP) in 1959, and has been a member of the AAP since then. She is also a member of their sub-committee on Child Abuse and Neglect.

Since 1965, she has been a Pediatric Physician on the staff of Carle Foundation Hospital and a member of the Carle Physician Group in Urbana, Illinois. As a Carle staff member she has also served as Head of the Department of Pediatrics at the University of Illinois College of Medicine at Urbana-Champaign from 1986-2007 and continues on medical school committees as an Emeritus Professor of Clinical Pediatrics. She is also a 20-year member of the University of Illinois Institutional Review Board (IRB). During her years at Carle, Kathleen Buetow has been particularly interested in fostering appropriate immunization practices and serves on Carle’s Immunization Committee. She has a special interest in Child Protection and is involved in many multidisciplinary efforts to prevent, identify and treat instances of child abuse and neglect. She has been involved for the past 20 years on a state Child Death Review Team which seeks to identify and remedy problems associated with Child Mortality.

More Details